TAK:NYSE
Takeda Pharmaceutical Co Ltd
$18.73
arrow_upward
+1.24%(+0.23) 1D
$18.80
arrow_upward
+0.35% (+0.066)bedtimeAfter hours
Closed: Oct 9, 4:00:05 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TAK...
Open
$18.37
High
$18.76
Low
$18.37
Mkt. cap
59.62B
Avg. vol.
2.37M
Volume
2.04M
Dividend
3.37%
Quarterly dividend
$0.16
Ex-dividend date
Sep 29, 2026
52-wk high
$19.10
52-wk low
$12.99
EPS
-$0.33
Beta
-0.06
Shares outstanding
3.20B
No. of employees
47K
Open
$18.37
High
$18.76
Low
$18.37
Mkt. cap
59.62B
Avg. vol.
2.37M
Volume
2.04M
Dividend
3.37%
Quarterly dividend
$0.16
Ex-dividend date
Sep 29, 2026
52-wk high
$19.10
52-wk low
$12.99
EPS
-$0.33
Beta
-0.06
Shares outstanding
3.20B
No. of employees
47K
News stories
From web sources and news partners
TradingView
·
52 minutes ago
'AI is all that matters': How 42 artificial intelligence stocks drive 67% of S&P 500 gains since 2024
Finimize
·
50 minutes ago
PM Capital Blamed A Narrow US Rally For Its September Dip
Stocktwits
·
13 minutes ago
Dow, S&P 500, Nasdaq Futures Climb After Oil In Focus As Trump Declares ‘Energy Ceasefire’ Between Russia And Ukraine: IREN, WFF, VSTM, CIFR Stocks In Focus
FXLeaders
·
5 hours ago
Dow Jones and Nasdaq Futures Start Higher Ahead of US Inflation Data
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees47K
FoundedJun 12, 1781
Headquarters-
SectorPharmaceutical industry
Websitetakeda.com